NDASEC stock news
This page provides real-time market news, earnings updates, and company announcements related to NDA Securities Ltd. (NDASEC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-23 23:37 IST
Nasus Pharma Announces Closing of $15.0 Million Private Placement
Finviz2026-02-13 13:03:45
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800
Finviz2026-02-13 14:54:40
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Finviz2026-02-13 15:01:04
Why Is Immunic Stock Soaring Friday?
Finviz2026-02-13 18:57:12
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Finviz2026-02-13 20:09:38
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
Finviz2026-02-16 17:24:48
Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Finviz2026-02-17 12:03:44
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Finviz2026-02-17 14:15:47
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-18 12:03:22
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Finviz2026-02-18 12:03:22
FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
Finviz2026-02-18 17:39:39
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Finviz2026-02-19 11:03:48
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Here's What Analysts Are Saying About Regeneron Pharmaceuticals (REGN)
Finviz2026-02-19 14:54:43
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
Finviz2026-02-20 00:06:02
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Finviz2026-02-20 16:15:09
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
Finviz2026-02-23 13:34:19
FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application
Finviz2026-02-23 13:51:07
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Finviz2026-02-13 20:09:38
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
Finviz2026-02-16 17:24:48
Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Finviz2026-02-17 12:03:44
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Finviz2026-02-17 14:15:47
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-18 12:03:22
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Finviz2026-02-18 12:03:22
FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
Finviz2026-02-18 17:39:39
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Finviz2026-02-19 11:03:48
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Here's What Analysts Are Saying About Regeneron Pharmaceuticals (REGN)
Finviz2026-02-19 14:54:43
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
Finviz2026-02-20 00:06:02
Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise
Finviz2026-02-20 16:15:09
Strong Analyst Confidence in C4 Therapeutics (CCCC)'s Cemsidomide Drives 270% Upside Potential
Finviz2026-02-20 17:03:42
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Finviz2026-02-20 19:48:38
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One
Finviz2026-02-23 13:34:19
FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application
Finviz2026-02-23 13:51:07
NDASEC stock price change
On the last trading day, NDASEC stock closed at 30.27 INR, with a price change of 3.49% for the day.
Trade stock futuresNDASEC stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more